Monetary Management Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,133
Closed -$123K 320
2018
Q2
$123K Sell
1,133
-438
-28% -$47.7K 0.05% 179
2018
Q1
$166K Sell
1,571
-257
-14% -$29.8K 0.07% 158
2017
Q4
$214K Sell
1,828
-17,227
-90% -$1.95M 0.09% 148
2017
Q3
$2.17M Buy
19,055
+463
+2% +$53.4K 0.91% 35
2017
Q2
$2.32M Sell
18,592
-190
-1% -$22.5K 0.95% 36
2017
Q1
$2.23M Sell
18,782
-1,870
-9% -$212K 0.97% 37
2016
Q4
$2.07M Sell
20,652
-2,137
-9% -$229K 0.96% 39
2016
Q3
$2.88M Buy
22,789
+10,105
+80% +$1.25M 1.33% 23
2016
Q2
$1.48M Buy
+12,684
New +$1.44M 0.69% 54
2016
Q1
Sell
-2,421
Closed -$241K 332
2015
Q4
$241K Buy
+2,421
New +$237K 0.12% 133

Other funds holding ZBH

Monetary Management Group's ZBH Position: Q3 2018 in Review

Monetary Management Group sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 1,133 shares — an estimated $123K sold.

Monetary Management Group first reported a position in ZBH in Q4 2015 and held it in 10 quarters. The position peaked at $2.88M in Q3 2016. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Monetary Management Group reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • Monetary Management Group sold 1,133 Zimmer Biomet shares in Q3 2018, an estimated $123K.
  • Monetary Management Group first reported a position in Zimmer Biomet in Q4 2015 and held it in 10 quarters.
  • Monetary Management Group's Zimmer Biomet position peaked at $2.88M in Q3 2016.
  • 891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Monetary Management Group's 13F filing for Q3 2018, filed 13 Nov 2018.